Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in <i>EGFR</i> -Mutant Lung Cancer

Adam J. Schoenfeld, Helena A. Yu, Michael Offin et al.|Clinical Cancer Research|2020

Cited by 381